Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196
Geck Do MK
InChi: InChI=1S/C15H21NO4/c1-10-7-6-8-11(2)14(10)16(13(17)9-19-4)12(3)15(18)20-5/h6-8
which can be used to investigate α9β1 and α4β1 integrin binding activity
CDDO-Im also significantly decreases sphere forming efficiency and tumorsphere size in both primary and secondary sphere cultures
Imatinib hydrochloride in fumarate Lipid lowering in healthy volunteersDescription: IC50 Value: 100 nM (PDGFR) ; 100 nM (c Kit) Imatinib is a multi target inhibitor of v Abl, c Kit and PDGFR with IC50 of 0. 6 M, 0. 1 M and 0. 1 M, respectively. Imatinib is used to treat chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs) and a number of other malignancies. in vitro: In vitro assays for inhibition of a panel of tyrosine and serine threonine protein kinases show that Imatinib inhibits the v Abl
US$ 18.00
US$ 16.00
US$ 18.00
US$ 15.75
US$ 20.00